Newly discovered orally active pure antiestrogens-Reference-Cited by-同舟云学术

Newly discovered orally active pure antiestrogens

Published:2006-09 Issue:18 Volume:16 Page:4959-4964
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Kanbe Yoshitake,Kim Myung-Hwa,Nishimoto Masahiro,Ohtake Yoshihito,Yoneya Takaaki,Ohizumi Iwao,Tsunenari Toshiaki,Taniguchi Kenji,Kaiho Shin-ichi,Nabuchi Yoshiaki,Araya Hiroshi,Kawata Setsu,Morikawa Kazumi,Jo Jae-Chon,Kwon Hee-An,Lim Hyun-Suk,Kim Hak-Yeop

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference25 articles.

1. ICI 182,780, a new antioestrogen with clinical potential

2. Novel antioestrogens

3. Effects of a non-steroidal pure antioestrogen, ZM 189,154, on oestrogen target organs of the rat including bones

4. Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs);ChemMedChem;2020-10-27

2. Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer;RSC Medicinal Chemistry;2020

3. Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD);Oncotarget;2017-10-10

4. Small-Molecule Modulation of Protein Homeostasis;Chemical Reviews;2017-08-04

5. Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD);Journal of Medicinal Chemistry;2016-08-29